UNSPSC 51452300: Anthelmintic benzodioxoles and butyrophenones and copper compounds and cyclohexanes and naphthalenes

This classification denotes Anthelmintic drugs made from or based in part on benzodioxoles, butyrophenones, copper compounds, cyclohexanes, or naphthalenes

UNSPSC 51452300 Anthelmintic benzodioxoles and butyrophenones and copper compounds and cyclohexanes and naphthalenes is a Class code under which state and local governments procure pharmaceuticals and medical countermeasures, including antibiotic tablets, opioid antagonists, and drug deactivation systems for public health and emergency response programs. Recent activity shows purchasing concentrated in state health departments and county health agencies acquiring specific pharmaceutical products for disease treatment, overdose response, and community health initiatives. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for supply of Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets under an Invitation for Bid process, with a 12-month initial term and two optional renewal years. Seminole County, Florida issued an IFB in June 2026 for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries, though that solicitation carried a response deadline of July 26, 2023, indicating a data anomaly in the source record.

Recent procurement activity under this code appears concentrated in Florida and Illinois, with issuing bodies limited to state and county health agencies. The Illinois award represents a high-volume, multi-year pharmaceutical supply contract typical of state-level health department operations, while the Seminole County opportunity targets narrower quantities of specialized public health commodities. Both solicitations emphasize compliance with federal and state regulations, E-Verify requirements, and insurance coverage standards. Cooperative purchasing vehicles—notably the MMCAP Infuse consortium in the Illinois award—feature prominently in recent activity, reducing barriers for vendors to access state and local pharmaceutical procurement. The code shows active but limited recent opportunities; firms pursuing this work should focus on state health department relationships and county emergency health programs in regions with documented recent activity.